International Myeloma Foundation

Daratumumab shows great promise in published report today

Dr. Durie

Week in Review

Toxic chemicals are toxic … and can cause cancer

Dr. Durie

Week in Review

Precision Medicine: Is It a Must, a Bust—or Something in Between?

Medical Test Tubes

Week in Review

Can the ASCO “Value Framework” work for myeloma patients?

Dr. Durie

Week in Review

New York Longevity Feast: What Can We Learn?

Dr. Durie

Week in Review

Research News Roundup: Promising Kyprolis Results, Another FDA Approval, Launch of a New Collaboration

New study links inherited genetic variant to poorer outcome for myeloma patients

DNA Structure graphic

Week in Review

FDA Approves Kyprolis® (Carfilzomib) for Combination Use in the Treatment of Patients with Relapsed Multiple Myeloma

Black Swan Research Initiative® Update

Week in Review

Members of International Myeloma Foundation’s Nurse Leadership Board Author Key Textbook for Nurses

Give Where Most Needed